Director, PRESIDENT AND CEO · Alto Neuroscience, Inc. · Alto Neuroscience, Inc. — Employee Stock Option (Right to Buy)
Side
A
Value
—
Shares
306.0K
Price
—
Executed
Feb 11, 2026
Disclosed
Feb 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 11 executedFeb 13, 2026 disclosed
ANRO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Alto Neuroscience, Inc. — Employee Stock Option (Right to Buy)
Ticker
ANRO
Shares
306.0K
Price per share
$0
Execution date (reported)
Feb 11, 2026
Owned after transaction
306.0K shares
Days from execution to publication
2
What this establishes
Etkin Amit filed this Form 4 reporting a grant or award of ANRO on Feb 11, 2026. It became public on Feb 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, PRESIDENT AND CEO
Etkin Amitcik:0002007795
Issuer
Alto Neuroscience, Inc.cik:0001999480
Revision history · 0
No field has changed since this record was first ingested.
